Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
INTRODUCTION
Distribution
Pharmacokinetics is a Greek word and kinesis means movement. It is the study of the action
of drug in the body over a period of time, including the processes of liberation, absorption,
distribution, biotransformation and excretion(LADME). Distribution in pharmacology is a
branch of pharmacokinetics describing reversible transfer of drug from one location to
another within the body.
Pharmacokinetic
s
Drug distribution refers to the movement of drug to and from the blood and various tissues of
the body (for example, fat, muscle, and brain tissue) and the relative proportions of drug in
the tissues.
After a drug is absorbed into the bloodstream, it rapidly circulates through the body; the
average circulation time of blood is 1 minute. As the blood recirculates, the drug moves from
the bloodstream into the body's tissues.
Once absorbed, most drugs do not spread evenly throughout the body. Drugs that dissolve in
water (water-soluble drugs), such as the antihypertensive drug atenolol Some Trade Names
TENORMIN, tend to stay within the blood and the fluid that surrounds cells (interstitial
space). Drugs that dissolve in fat (fat-soluble drugs), such as the anesthetic drug halothane,
tend to concentrate in fatty tissues. Other drugs concentrate mainly in only one small part of
the body (for example, iodine concentrates mainly in the thyroid gland), because the tissues
there have a special attraction for and ability to retain (affinity) the drug.
Drugs penetrate different tissues at different speeds, depending on the drug's ability to cross
membranes. For example, the anesthetic thiopental Some Trade Names PENTOTHAL, a
highly fat-soluble drug, rapidly enters the brain, but the antibiotic penicillin, a water-soluble
drug, does not. In general, fat-soluble drugs can cross cell membranes more quickly than
water-soluble drugs can. For some drugs, transport mechanisms aid movement into or out of
the tissues.
Some drugs leave the bloodstream very slowly, because they bind tightly to proteins
circulating in the blood. Others quickly leave the bloodstream and enter other tissues, because
they are less tightly bound to blood proteins. Some or virtually all molecules of a drug in the
blood may be bound to blood proteins. The protein-bound part is generally inactive. As
unbound drug is distributed to tissues and its level in the bloodstream decreases, blood
proteins gradually release the drug bound to them. Thus, the bound drug in the bloodstream
may act as a reservoir for the drug.
Some drugs accumulate in certain tissues, which can also act as reservoirs of extra drug.
These tissues slowly release the drug into the bloodstream, keeping blood levels of the drug
from decreasing rapidly and thereby prolonging the effect of the drug. Some drugs, such as
1
DRUG DISTRIBUTION
those that accumulate in fatty tissues, leave the tissues so slowly that they circulate in the
bloodstream for days after a person has stopped taking the drug.
Distribution of a given drug may also vary from person to person. For instance, obese people
may store large amounts of fat-soluble drugs, whereas very thin people may store relatively
little. Older people, even when thin, may store large amounts of fat-soluble drugs because the
proportion of body fat increases with age.1
The bloodstream carries drugs from the site of absorption to the target site and also to sites of
metabolism or excretion, such as the liver, kidneys, and, in some cases, the lungs. Many
drugs are bound to plasma proteins, and in some cases more than 90 percent of the drug
present in the plasma is bound in this way. This bound fraction is inert. Protein binding
reduces the overall potency of a drug and provides a reservoir to maintain the level of the
active drug in blood plasma. To pass from the bloodstream to the target site, drug molecules
must cross the walls of blood capillaries. This occurs rapidly in most regions of the body. The
capillary walls of the brain and spinal cord, however, are relatively impermeable, and in
general only drugs that are highly lipid-soluble enter the brain in any appreciable
concentration.2
Once a drug has gained access to the blood stream it gets distributed to other tissues that
initially had no drug. So, concentration gradient being in the direction of plasma to tissues.
The extent of distribution of a drug depends on its lipid solubility, ionization at physiological
pH, extent of binding to plasma and tissue proteins and difference in regional blood flow.
Movement of drug proceeds until an equilibrium is established between unbound drug in
plasma and tissue fluids. Subsequently there is a parallel decline in both due to elimination.*
2
DRUG DISTRIBUTION
DESCRIPTION
The volume of distribution
The volume of distribution of a drug is property that quantifies the extent of distribution. By
the process of distribution a drug diffuses or is transferred from intravascular space to
extravascular space (body tissues). These spaces are described mathematically as volume(s)
of distribution.
In the simplest of terms, a drug's volume of distribution is that volume of bodily fluid into
which a drug dose is dissolved. Therefore, if we know the dose that was given, and we can
measure the serum level (concentration), then we can calculate a volume:
Of course, the human body is not a glass beaker. Drug is distributing in and out of many
tissue compartments while it is simultaneously being eliminated.3 Since the drug does not
actually distribute into 20 L of body water, with the exclusion of the rest of it this is only an
apparent volume of distribution which can be defined as the volume that would accommodate
all the drug in the body, if the concentration through out was the same as in plasma.*
Volume of distribution may be increased by renal failure (due to fluid retention) and liver
failure (due to altered body fluid and plasma protein binding). Conversely it may be
decreased in dehydration. The initial volume of distribution describes blood concentrations
prior to attaining the apparent volume of distribution and uses the same formula.
Therefore the dose required to give a certain plasma concentration can be determined if the
VD for that drug is known. The VD is not a real volume; it is more a reflection of how a drug
will distribute throughout the body depending on several physicochemical properties, e.g.
solubility, charge, size, etc.
The units for Volume of Distribution are typically reported in (ml, liter, or liter)/kg body
weight. The fact that VD is a ratio of a theoretical volume to a fixed unit of body weight
explains why the VD for children is typically higher than that for adults, even though children
are smaller and weigh less. As body composition changes with age, VD decreases.4
Blood Flow
The rate at which a drug reaches different organs and tissues will depend on the blood flow to
those regions. Equilibration is rapidly achieved with heart, lungs, liver, kidneys and brain
where blood flow is high. Skin, bone, and depot fat equilibrate much more slowly.
3
DRUG DISTRIBUTION
Bone 0.02 5
Brain 0.5 14
Fat 0.03 4
Heart 0.6 4
Kidneys 4.0 22
Liver 0.8 27
Muscle 0.025 15
Skin 0.024 6
It would be expected that total drug concentration would rise most rapidly in these organs.
Certain organs such as the adrenals (1.2/0.2%) and thyroid (2.4/1%) also have large perfusion
rates.
Lipid Solubility
Lipid solubility will affect the ability of the drug to bind to plasma proteins and to cross lipid
membrane barriers.
Very high lipid solubility can result in a drug initially partitioning preferentially into highly
vascular lipid-rich areas. Subsequently these drugs slowly redistribute into body fat where
they may remain for long periods of time.
Effects of pH
Effects of pH on the partitioning or "trapping" of drugs will not be as dramatic as those seen
between the stomach and plasma since the pH differences are not as great. Nevertheless, even
small pH differences have significant effects and so acidic drugs will still tend to accumulate
where the pH is higher while bases do the reverse.
The rate of movement of a drug out of circulation will depend on its degree of ionization and
therefore its pK.
4
DRUG DISTRIBUTION
Changes in pH occurring in disease may also affect drug distribution. For example, blood
becomes more acidic if respiration is inadequate. Also, the pH of milk can increase as much
as 0.7 of a pH unit in animals with mastitis.
Capillary Permeability
The ability of a drug to reach various tissues will depend on the permeability of the
capillaries at the site in question. For example, the capillaries in liver are extremely
permeable, while those at the blood-brain barrier lie at the other extreme. Drugs can pass
through the epithelial cells or between them through the gap junctions.
Thus, molecular size is the major factor affecting the permeability of water-soluble drugs
across capillaries.
Inflammation of the epithelial layer may increase its permeability and allow charged and,
therefore, normally impermeant drugs (for example, penicillin and streptomycin) to attain
therapeutic concentrations in meningitis.
Body water constitutes as much as 75% of the total body weight of very lean animals and as
little as 45% in very fat ones. The average is about 60%. This is distributed between
intracellular fluid (~35% of body weight), interstitial fluid (~18%), blood plasma (~5%), and
transcellular fluid (~2%).
5
DRUG DISTRIBUTION
Transcellular fluids are separated from the interstitial fluid by an epithelium. They include:
The distribution of drugs between these body water compartments will depend on their
volume and the barriers (for example, lipid membranes, plasma binding proteins, pH
gradients) they encounter.
Fat: Highly lipid soluble drugs accumulate in fat (for example, chlorinated hydrocarbons).
Larger doses of lipid-soluble drugs may be necessary in obese animals.
Bone: Some drugs (for example, lead, fluoride, tetracyclines) are deposited in bone and teeth.
Drug Reservoirs
Sites other than the site of action can act as reservoirs for a drug. For example, plasma
proteins can sequester digitoxin and phenytoin, fat can sequester thiopental and
organochlorine pesticides, and bone can sequester tetracyclines and lead. The rate at which a
drug is released from a reservoir is governed by the same factors as those described for its
distribution. Such reservoirs can be useful in achieving a prolonged effect with an otherwise
short-acting drug.
6
DRUG DISTRIBUTION
Increasing concentration of the drug can progressively saturate the binding site. Fractional
binding may be lower when large amounts of the drug are given . The generally expressed
percentage binding refers to usual therapeutic plasma concentration of the drug . The
clinically significant implications of plasma protein binding are:
1) Highly plasma protein bound drugs are largely restricted to the vascular
compartment and tend to have lower volumes of distribution
2) The bound fraction is not available for action. However it is in equilibrium with the
free drug in plasma and dissociates when the concentration of the latter is required
due to elimination. Plasma protein binding does provide temporary storage of the
drug.
3) High degree of protein binding generally makes the drug long acting, because
bound fraction is not available for metabolism or excretion, unless it is actively
extracted by liver or kidney tubules.
5) One drug can bind to many sites on the albumin molecule. Conversely more than
one drug can bind to same site. This can give rise to displacement interaction among
drugs bound to the same sites: drug bound with higher affinity will displace that
bound with lower affinity.
7
DRUG DISTRIBUTION
Albumin and other plasma proteins are essentially contained within blood vessels, so bound
drug is similarly restricted. When more than 70-80% of the drug in plasma is protein bound,
it acts as a considerable reservoir for the drug. The effect of protein binding on the
distribution of a drug between blood plasma and transcellular fluid (relatively protein-free)
can cause toxicity. If the drug is highly protein bound, the volume of distribution will be very
low. On the other hand the drug of low affinity will in free form dominantly which creates a
chance of toxicity.
In brain tissue the blood brain barrier is a difficult way for drugs to cross. In the treatment
of epilapsy, lavodopa-the pro drug of dopamin is used because of the nice distribution
capacity of lavodopa.*
Two or more different drugs may bind to the same site on plasma proteins. Thus,
administration of a second drug may significantly affect the binding of the first drug.
Changes in binding have the greatest effect on the proportion of free drug when the percent
binding is high. Reducing binding from 98% to 96% will double the amount of free drug (2%
to 4%). With only 60% bound, the reduction would have to be 20% to double the free drug
(40% to 80%).
Groups on the protein molecules that are responsible for electrostatic interactions with
drugs include:
The of lysine and N- terminal amino acids,
The of histidine, the - S- of cysteine, and
The - COO- of aspartic and glutamic acid residues.
In order to achieve reasonably stable complexes, however, it is likely that in most cases the
initial electrostatic attraction is reinforced at close range by van der Waal's forces (dipole-
dipole; dipole-induced dipole; induced dipole-induced dipole) and hydrogen bonding.
8
DRUG DISTRIBUTION
Conclusion
9
DRUG DISTRIBUTION
Bibliography
1. http://www.merck.com/mmhe/sec02/ch011/ch011d.html
2. Britannica Ultimate Reference Suite-CD Edition2007
3. http://www.rxkinetics.com/pktutorial/1_3.html
4. http://en.wikipedia.org/wiki/Volume_of_distribution
5. http://web.vet.cornell.edu/public/pharmacokinetics
/freeDEF/other_factors.html#blood_flow
6. http://www.merck.com/mmhe/sec02/ch011/ch011d.html
10